Published in Anal Biochem on August 01, 1976
The Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide. Infect Immun (1994) 1.02
Photoaffinity labeling of the beta-adrenergic receptor from cultured lymphoma cells with [125I]iodoazidobenzylpindolol: loss of the label with desensitization. Proc Natl Acad Sci U S A (1983) 0.88
The isolation and properties of a second glycoprotein (LGP-II) from the articular lubricating fraction from bovine synovial fluid. Biochem J (1979) 0.84
Serodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerci. Clin Diagn Lab Immunol (2001) 0.77
A method for the preparation of low-pH dodecyl sulphate/polyacrylamide-gradient gels. Biochem J (1981) 0.77
Immunochemical probing of the structure and cofactor of NADH dehydrogenase from Paracoccus denitrificans. Biochem J (1987) 0.75
Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA (1997) 5.85
Summertime haze air pollution and children with asthma. Am J Respir Crit Care Med (1997) 2.28
Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys (2001) 2.14
Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med (1999) 2.09
Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol (2005) 1.96
Methods for the quantification of DNA double-strand breaks determined from the distribution of DNA fragment sizes measured by pulsed-field gel electrophoresis. Radiat Res (1995) 1.61
Camurati-Engelmann disease: a late and sporadic case with metaphyseal involvement. Eur Radiol (1999) 1.61
Reliability of molecular weight determination of proteins by polyacrylamide gradient gel electrophoresis in the presence of sodium dodecyl sulfate. Anal Biochem (1978) 1.57
Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys (1994) 1.51
Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate? Radiother Oncol (1997) 1.46
Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective study. AIDS (1991) 1.46
The role of titratable acidity in acid aerosol-induced bronchoconstriction. Am Rev Respir Dis (1987) 1.44
Additional data on the population distribution of human serum albumin genes; three new variants. Ann Hum Genet (1973) 1.35
Hypoxia as a target for combined modality treatments. Eur J Cancer (2002) 1.24
Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat Res (1996) 1.19
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br J Cancer (2006) 1.19
Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database Syst Rev (2005) 1.17
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types. Br J Cancer (2008) 1.15
A simple technique for the isolation of monoclonal IgG and IgA. Rev Eur Etud Clin Biol (1970) 1.14
Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum. Cancer Gene Ther (2001) 1.12
Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells. Int J Radiat Biol (1997) 1.11
Immunoglobulins and transferrin in marine lamprey sera. Nature (1967) 1.11
Selective serum IgA deficiency. Frequency among 15,200 French blood donors. Vox Sang (1973) 1.10
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Ann Oncol (2008) 1.08
A statewide initiative to improve the care of hospitalized pneumonia patients: The Connecticut Pneumonia Pathway Project. Am J Med (2001) 1.07
Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities. Biochemistry (1999) 1.06
Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy. Med Phys (2010) 1.06
Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation. Gene Ther (2001) 1.05
Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas. FEMS Immunol Med Microbiol (2001) 1.04
Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas. Eur J Cancer (2000) 1.04
Frequency of monoclonal gammapathy ('M components') in 13,400 sera from blood donors. Vox Sang (1972) 1.04
Purification of the human serum inter-alpha-trypsin inhibitor by zinc chelate and hydrophobic interaction chromatographies. Anal Biochem (1980) 1.02
Tumor-specific gene delivery using genetically engineered bacteria. Curr Gene Ther (2003) 1.00
Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol (1999) 0.99
Molecular weight estimation of proteins by electrophoresis in linear polyacrylamide gradient gels in the absence of denaturing agents. Anal Biochem (1979) 0.98
Human monoclonal antibody against Rh(D) antigen: partial characterization of the Rh(D) polypeptide from human erythrocytes. Blood (1987) 0.97
Metal fume fever. Occup Med (1994) 0.97
Phased attenuation correction in respiration correlated computed tomography/positron emitted tomography. Med Phys (2006) 0.96
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol (2007) 0.96
Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol (1993) 0.95
Pulmonary effects of inhaled zinc oxide in human subjects, guinea pigs, rats, and rabbits. Am Ind Hyg Assoc J (1992) 0.95
Monoclonal gammopathies in asymptomatic HIV-seropositive patients. Clin Chem (1987) 0.93
Human albumin genetic variants: an attempt at a classification of European allotypes. Am J Hum Genet (1987) 0.93
Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha. Appl Environ Microbiol (1999) 0.92
Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Ann Oncol (2007) 0.92
Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin's lymphomas. Hematol Oncol (1994) 0.92
Flow cytometric monitoring of allergen induced basophil activation. Cytometry (1995) 0.91
Oxygenation of head and neck tumors. Cancer (1993) 0.90
Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenström's macroglobulinemia. Acta Med Scand (1982) 0.90
Independent and functional validation of a multi-tumour-type proliferation signature. Br J Cancer (2012) 0.90
Structural characterization of the human albumin variant "Pollibauer". Rev Fr Transfus Immunohematol (1984) 0.90
["Essential" dysglobulinemia in aged subjects]. Nouv Rev Fr Hematol (1966) 0.90
Efficient isolation of total RNA from Clostridium without DNA contamination. J Microbiol Methods (2001) 0.90
Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours. Br J Cancer (2003) 0.90
The use of radiation-induced bacterial promoters in anaerobic conditions: a means to control gene expression in clostridium-mediated therapy for cancer. Radiat Res (2001) 0.90
Flow cytometric evaluation of human basophils. Cytometry (1993) 0.89
Direct phasing at low resolution of a protein copurified with human paraoxonase (PON1). Acta Crystallogr D Biol Crystallogr (2003) 0.89
Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br J Cancer (2000) 0.89
A global calibration model for a-Si EPIDs used for transit dosimetry. Med Phys (2007) 0.88
Anti-DNA autoantibody activity and idiotypic relationships of human monoclonal proteins. Eur J Immunol (1984) 0.88
Symptomatic bronchoconstriction after short-term inhalation of sulfur dioxide. Am Rev Respir Dis (1987) 0.88
Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols. Am Rev Respir Dis (1988) 0.88
Non-invasive tumour perfusion measurement by dynamic CT: preliminary results. Radiother Oncol (1997) 0.87
Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters. Anticancer Res (2001) 0.87
Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity. Vox Sang (1984) 0.87
Study of the frequency of kappa and lambda light chains in 347 sera containing a monoclonal IgG, IgA, IgD, or Bence-Jones protein. Rev Eur Etud Clin Biol (1970) 0.87
Identification of the human albumin variant "Gainesville" with proalbumin "Christchurch". Rev Fr Transfus Immunohematol (1983) 0.86
Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters. Appl Environ Microbiol (2001) 0.86
Prospective follow-up of monoclonal gammopathies in HIV-infected individuals. Br J Haematol (1993) 0.85
Purification and partial characterization of a hepatocyte antiproliferative glycopeptide. J Cell Biochem (1989) 0.85
Systematic survey of monoclonal gammapathies in the sera from blood donors. Transfusion (1979) 0.85
In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment. Int J Radiat Oncol Biol Phys (2001) 0.84
The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy. Nucl Med Commun (2001) 0.84
The extracellular domain of the human erythropoietin receptor: expression as a fusion protein in Escherichia coli, purification, and biological properties. Prep Biochem Biotechnol (1999) 0.84
Isotypic analysis of grass pollen-specific immunoglobulins in human plasma. 1. Specialization of certain classes and subclasses in the immune response. Int Arch Allergy Immunol (1993) 0.84
Prediction of DVH parameter changes due to setup errors for breast cancer treatment based on 2D portal dosimetry. Med Phys (2009) 0.83
Clostridium spores for tumor-specific drug delivery. Anticancer Drugs (2002) 0.83
Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV. AIDS (1988) 0.83
Verification of treatment parameter transfer by means of electronic portal dosimetry. Med Phys (2004) 0.83
Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer. Strahlenther Onkol (2011) 0.82
[Studies on monoclonal IgG. I. Isolation method based on the solubility of these proteins, and study, by electrophoresis in starch-urea gel, of reduction-alkylation products of these immunoglobulins]. Rev Fr Transfus (1970) 0.82
Serum neopterin and beta 2-microglobulin in anti-HIV positive blood donors. Lancet (1986) 0.82
Follow-up of monoclonal gammopathies in asymptomatic HIV-infected subjects. Clin Chem (1989) 0.82
Interspecies differences in the phagocytic activity of pulmonary macrophages subjected to acidic challenge. Fundam Appl Toxicol (1992) 0.82
Isotypic analysis of grass-pollen-specific immunoglobulins in human plasma. 2. Quantification of the IgE, IgM, IgA class and the IgG subclass antibodies. Int Arch Allergy Immunol (1993) 0.82
[Genetic variants of human albumin: structural characterization of allotypes used as references for electrophoretic classification]. Rev Fr Transfus Immunohematol (1988) 0.82
Serum neopterin and beta 2-microglobulin concentrations in monoclonal gammopathies. Acta Med Scand (1988) 0.82
Potential bronchoconstrictor stimuli in acid fog. Environ Health Perspect (1989) 0.82
BOLD contrast fMRI of whole rodent tumour during air or carbogen breathing using echo-planar imaging at 1.5 T. Eur Radiol (2001) 0.82
A human monoclonal IgG1 with anti-idiotypic activity against anti-human thyroglobulin autoantibody. J Immunol (1984) 0.81